Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
11.09
+0.15 (1.37%)
At close: Feb 27, 2026, 4:00 PM EST
10.00
-1.09 (-9.83%)
After-hours: Feb 27, 2026, 5:37 PM EST
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $971.11 million as of February 27, 2026. Its market cap has increased by 58.87% in one year.
Market Cap
971.11M
Enterprise Value
1.03B
1-Year Change
58.87%
Ranking
Category
Stock Price
$11.09
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $971.11M, an increase of 115.35%. That is a compound annual growth rate of 6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 961.20M | 27.45% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 1.04B |
| Geron | 1.04B |
| AbCellera Biologics | 1.03B |
| Aktis Oncology | 1.02B |
| Compass Therapeutics | 1.02B |
| Xencor | 1.01B |
| Ventyx Biosciences | 1.00B |
| UroGen Pharma | 985.56M |